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Abstract
Background: Pterostilbene, a naturally occurring phenolic compound produced by agronomically
important plant genera such as Vitis and Vacciunium, is a phytoalexin exhibiting potent antifungal
activity. Additionally, recent studies have demonstrated several important pharmacological
properties associated with pterostilbene. Despite this, a systematic study of the effects of
pterostilbene on eukaryotic cells at the molecular level has not been previously reported. Thus, the
aim of the present study was to identify the cellular pathways affected by pterostilbene by
performing transcript profiling studies, employing the model yeast Saccharomyces cerevisiae.
Methods: S. cerevisiae strain S288C was exposed to pterostilbene at the IC50 concentration (70
µM) for one generation (3 h). Transcript profiling experiments were performed on three biological
replicate samples using the Affymetrix GeneChip Yeast Genome S98 Array. The data were
analyzed using the statistical methods available in the GeneSifter microarray data analysis system.
To validate the results, eleven differentially expressed genes were further examined by quantitative
real-time RT-PCR, and S. cerevisiae mutant strains with deletions in these genes were analyzed for
altered sensitivity to pterostilbene.
Results:  Transcript profiling studies revealed that pterostilbene exposure significantly down-
regulated the expression of genes involved in methionine metabolism, while the expression of
genes involved in mitochondrial functions, drug detoxification, and transcription factor activity
were significantly up-regulated. Additional analyses revealed that a large number of genes involved
in lipid metabolism were also affected by pterostilbene treatment.
Conclusion:  Using transcript profiling, we have identified the cellular pathways targeted by
pterostilbene, an analog of resveratrol. The observed response in lipid metabolism genes is
consistent with its known hypolipidemic properties, and the induction of mitochondrial genes is
consistent with its demonstrated role in apoptosis in human cancer cell lines. Furthermore, our
data show that pterostilbene has a significant effect on methionine metabolism, a previously
unreported effect for this compound.
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Background
Pterostilbene is a naturally-occurring phytoalexin identi-
fied in several plant species. It belongs to a group of phe-
nolic compounds known as stilbenes, and is found in the
heartwood of sandalwood (Pterocarpus santalinus) [1] and
P. marsupium [2]. It was also identified in the leaves of Vitis
vinifera [3], in infected grape berries of var. Chardonnay
and Gamay [4], and in healthy and immature berries of
var. Pinot Noir and Gamay [5]. Pterostilbene has also
been found in berries of some Vacciunium  species [5].
Pterostilbene, one of the most extensively studied second-
ary metabolites found in grapes and wine, is a dimethyl-
ether analog of resveratrol that is well known for its
hypolipidemic activity. A considerable amount of
research effort has been expended to address the biochem-
ical and physiological effects of pterostilbene in animal
and microbial systems. For example, the antioxidative
activity of pterostilbene was first demonstrated in vitro by
its inhibition of methyl linoleate oxidation [6]. Pterostil-
bene was reported to scavenge 1,1-diphenyl-2-picryl-
hydrazyl (DPPH) free radicals and to inhibit the oxidation
of citronellal, and lipid peroxidation in rat liver micro-
somes and in cultured human fibroblasts [7]. Pterostil-
bene isolated from Anogeissus acuminata (Family
Combretaceae) is cytotoxic against a number of cancer
cell lines, including human breast cancer and murine lym-
phoid neoplasma cells [8,9]. More recently, it has been
demonstrated that pterostilbene can reduce cholesterol
levels in vivo in hamsters through the activation of the per-
oxisome proliferator-activated receptor α (PPARα) [10].
Pterostilbene has been reported to reduce glucose and
increase plasma insulin levels significantly in normal and
diabetic rats [11]. Furthermore, pterostilbene has been
shown to be cancer-chemopreventive [8,12] and anti-
inflammatory [13].
Investigation of the pathogen-host interactions of Vitis
vinifera has led to the hypothesis that resistance is not due
to preformed physical or chemical factors, but rather to an
active defense mechanism that is triggered by the patho-
gen, of which stress metabolites including resveratrol, α-
viniferin and ε-viniferin are an important component
[14]. Pterostilbene, produced in leaf tissues by various
species of the Vitaceae family following fungal infection,
proved to have more potent antifungal activity than res-
veratrol (reviewed in [3,15,16]). However, the mecha-
nism by which pterostilbene inhibits fungi is not well
understood. Results from early studies suggested that the
biological activities of the compound mainly involved
effects on the plasma membrane [5,17], and destruction
of ribosomes, endoplasmic reticulum, and mitochondrial
membranes [17]. Further information on its precise
mechanism of action would be useful not only for its
potential development as a drug, but also in understand-
ing its ecological significance to producing plant species.
In the present study, using transcript profiling analysis, we
monitored the gene expression profile of yeast cells
treated with pterostilbene in an effort to identify the
molecular pathways affected by this compound.
Methods
Yeast strains and media
S. cerevisiae S288C (MATα, SUC2, mal, mel, gal2, CUP1,
flo1, flo8-1), obtained from ATCC (Manassas, VA), was
used in the microarray experiments. The deletion strains
and the isogenic wild type strain (BY4742) were obtained
from Open Biosystems (Huntsville, AL). Synthetic dex-
trose (SD) medium, containing 0.67% (w/v) yeast nitro-
gen base without amino acids and 2% (w/v) dextrose, was
used to grow the wild type S288C strain. Standard Yeast
Peptone Dextrose (YPD) medium (1% yeast extract, 2%
peptone, 2% dextrose) was used to grow the deletion
strains and their respective isogenic wild type control. In
all cases, the medium was buffered with 0.165 M 3- [N-
Morpholino]propanesulfonic acid (MOPS) (Sigma-
Aldrich Corp.) and the pH was adjusted to 7.0 with
NaOH.
IC50 determination and yeast cultures for microarray 
studies
IC50 value (concentration of inhibitor required for 50 per-
cent inhibition of growth) was first determined in a con-
ventional microplate assay. The obtained IC50 was then
further confirmed in 50-ml large-scale cultures as previ-
ously described in order to closely mimic the microarray
experimental conditions [18]. For microarray experi-
ments, a single colony of S. cerevisiae was inoculated into
25 ml of SD medium and grown overnight at 30°C with
shaking at 200 rpm. The culture was used to inoculate 50-
ml of SD medium to an A600 of 0.1. Three independent 50-
ml cultures were grown for pterostilbene treatments. In
parallel, another set of three independent cultures were
grown for solvent treatments which served as the
untreated controls. When the cultures reached an A600 of
0.2, pterostilbene was added at 70 µM concentration from
a stock solution of 0.5 M dissolved in dimethyl sulfoxide
(DMSO). In the control cultures, 0.25% of DMSO was
simultaneously added. The cultures were allowed to grow
until an A600 of 0.5 was reached [18]. Cells were harvested
by centrifugation at 500 × g in a Sorvall centrifuge using a
SH-3000 rotor. The cells were flash-frozen in liquid nitro-
gen and stored at -80°C until use.
RNA preparation and hybridization to Affymetrix 
GeneChips
Total RNA was isolated using the Qiagen RNeasy® Midi-kit
(Qiagen, Inc., Valencia, CA) with modifications as previ-
ously described [18]. RNA was processed for target prepa-
ration using the GeneChip One-Cycle Target Labeling and
Control Reagents kit (Affymetrix, Santa Clara, CA),BMC Medical Genomics 2008, 1:7 http://www.biomedcentral.com/1755-8794/1/7
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according to the manufacturer's protocol. Microarray
hybridization was performed using the Affymetrix Gene-
Chip Yeast Genome S98 Array using protocols described
by Affymetrix (Santa Clara, CA). All microarray data are
deposited at the Gene Expression Omnibus as GSE10554.
Microarray data analysis
Normalized data from the Affymetrix software were ana-
lyzed using the GeneSifter microarray data analysis system
(VizX Labs LLC, Seattle, WA; [19]). This program identi-
fies differentially expressed genes and establishes the bio-
logical significance based on Gene Ontology (GO)
classification [20,21] into biological process, molecular
function and cellular component. The GeneSifter program
also produces z-score reports. A z-score is a statistical rat-
ing of gene ontologies and indicates whether each GO
term occurs more or less frequently than expected. The
differential expression of genes was calculated by averag-
ing the normalized triplicate samples and running a pair-
wise analysis [22,23]. Statistical significance was
determined using Student t-test (two tail, unpaired) with
correction factor for false discovery rate (Benjamini and
Hochberg) included [24]. Gene lists generated using Gen-
eSifter were further analyzed using the Saccharomyces
Genome Database [25].
Quantitative real-time RT-PCR assay
To confirm the results from microarray experiments, real-
time quantitative RT-PCR was carried out using the same
RNA preparations that were used in the microarray exper-
iments. Total RNA was treated with DNase I and the RT-
PCR reaction was performed as described [18]. The
sequences of the primers for each gene selected for the
assays are listed in Table 1. Additionally, linear regression
analysis as well as an F-Test to assess goodness-of-fit was
performed on log2-transformed expression ratios (pter-
ostilbene treated:untreated cells) obtained from real-time
RT-PCR and microarray experiments (see Additional file
1: Correlation between expression ratios obtained from
quantitative real-time RT-PCR and microarray experi-
ments) using the Microsoft Excel Analysis ToolPak add-in
module, and a statistically-significant (p < 0.05) correla-
tion between the two methods was indicated.
Sensitivity assays with yeast mutants
Cells were grown overnight in YPD broth (pH 7.0, MOPS
buffered) until the optical density of 3.0 at A600  was
reached. For mutants, G418 at the concentration of 200
µg/ml was added to the broth. Seven serial 1:5 dilutions
of the overnight cultures were prepared in appropriate
medium and plated on YPD agar containing either 110
µM of pterostilbene or 1% DMSO as control. The plates
were photographed after incubating for 2 days at 30°C.
Results
IC50 determination in S. cerevisiae
Pterostilbene is known to possess strong antifungal activ-
ity [16]. In this study, in order to investigate how pterostil-
bene functions in fungal cells, we determined the
consequences of exposure to this compound by monitor-
ing the whole-genome transcriptional response in the
model yeast Saccharomyces cerevisiae. We made use of S.
cerevisiae since it has been extensively used for elucidating
the molecular targets of antifungal and therapeutic com-
pounds (reviewed in [26,27]). We first determined the
IC50 value for pterostilbene in S. cerevisiae cells using a
combination of microplate-based and large-scale culture
assays as previously described [18]. The IC50 was deter-
mined to be 70 µM based on the average value from four
independent experiments (Figure 1), and this concentra-
tion was used for subsequent microarray studies.
Categories of genes responding to pterostilbene
Our results demonstrate that pterostilbene significantly (p
< 0.05) affected the expression of over a thousand genes
under our experimental conditions, with the up- and
down-regulation of 1007 and 182 genes, respectively (see
Additional file 2: List of all significant pterostilbene-
responding genes). The most immediate observation is
the very high fraction of up-regulated genes, indicating
Table 1: Gene-specific primer sequences for quantitative real-time RT-PCR analysis
Gene name Forward Primer Reverse primer ORF
BAG7 5'-TGCTTCCAAGGTCACGTGC-3' 5'-GATGTATGGTAAAATTGTTGGAGTCAG-3' YOR134W
RSB1 5'-ACCCGTTGTTGTTACCGTTTG-3' 5'-GATAGCCATCCCAACCGACA-3' YOR049C
UPC2 5'-TTCGAGGACTGAAACTGGACTG-3' 5'-TCTAGGCGGTGAGATGAAACG-3' YDR213W
OAF1 5'-CAGTGGTTTACGTCAGGGTCC-3' 5'-CGTTTGCTCTTTTGAACCACC-3' YAL051W
INO4 5'-ATGAGGCAAAAACCGGCAG-3' 5'-TTTGTTCTTGTACGGGATCGC-3' YOL108C
MET3 5'-GTGCCTCCCACTTCATTGTTG-3' 5'-GAGTTCTTACCTGGGCCCG-3' YJR010W
AZR1 5'-TATTACCTGGCGTTGCTTTCG-3' 5'-TGAGAAGCGAGCATGGAACTT-3' YGR224W
PDR3 5'-CTGCGGCATCAAGATCGAT-3' 5'-GCTAGGCGCAGAATGTTGTCT-3' YBL005W
RTG1 5'-CAGTAAGACCGCCAGCAAAGA-3' 5'-CACCATACCCTCCGTACTCGA-3' YOL067C
RTG3 5'-CAATTGGGAGCCACCGTTAT-3' 5'-CCAGCATGATTGTGGTTACCG-3' YBL103C
RLM1 5'-AAATACCGGGCTGACTCCATAC-3' 5'-GTGCCTAGTGGTGTTTGAGCAG-3' YPL089CBMC Medical Genomics 2008, 1:7 http://www.biomedcentral.com/1755-8794/1/7
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many different biological processes are affected by pter-
ostilbene (Table 2). Of these, 44 genes were up-regulated
more than 10-fold. The majority of the genes showed
fold-changes ranging between 2.0 to 5.0, while approxi-
mately 200 genes showed fold-changes of 5.0 to10.0
(Table 2).
To explore the biological significance of the observed
transcriptome response to pterostilbene, a z-score report
was generated (Table 3) using the GeneSifter software
[19]. A positive z-score indicates that more genes than
expected by chance alone fulfill the criterion in a specific
ontology term, while a negative z-score indicates that the
term occurs less frequently than expected [22]. Pterostil-
bene affected the expression of genes that were associated
with a diverse array of biological, molecular and cellular
ontologies. As shown in Table 3, the most significantly
enriched ontologies identified for the up-regulated genes
included "response to drug," "regulation of transcription
from PolII promoter," "mitochondrion organization and
biogenesis," and "protein folding," with z-up scores of
5.05, 2.4, 2.12, and 4.24 respectively (Table 3, under Bio-
logical Process). Related processes were also significantly
over-represented under Molecular Function, as repre-
sented by the following categories: "ABC transporter activ-
ity," "transcription factor activity," "ATPase activity,"
"peptidase activity," and "chaperone activity," with z-
scores of 3.02, 4.67, 2.24, 2.12, and 3.56 respectively
(Table 3, under Molecular Function). Among the down-
regulated genes, terms associated with the biological proc-
ess "amino acid and derivative metabolism" (specifically,
the subcategory of "methionine metabolism"), and the
cellular component "cell wall" were over-represented with
z-scores of 5.08 and 8.22, respectively.
As mentioned, pterostilbene is involved in fatty acid and
lipid catabolism through activation of the peroxisome
proliferator-activated receptor α (PPARα) [10]. With
respect to the gene ontology analysis (Table 3), the effect
on lipid metabolism by pterostilbene was observed to be
less statistically significant, however further examination
revealed several important genes associated with lipid
metabolism within the microarray data (Table 4). These
included several genes involved in fatty acid breakdown
including  FOX2  (multifunctional beta-oxidation pro-
tein), ECI1 (peroxisomal ∆3, ∆2-enoyl-CoA isomerase),
and OAF1 (oleate-activated transcription factor). In addi-
tion, many genes involved in the biosynthesis of fatty
acids, phospholipids and sphingolipids were up-regulated
by pterostilbene treatment, as well as 8 genes involved in
the regulation of lipid metabolism. The latter include
OAF1 (involved in regulation of beta-oxidation of fatty
acids) [28,29], UPC2 (involved in regulation of sterol bio-
synthesis and transport) [30], and INO4 (involved in reg-
ulation of phospholipid metabolism) [31]. Furthermore,
two additional genes, MGA2 and SPT23, encoding endo-
plasmic reticulum membrane proteins, Spt23p and
Mga2p, respectively, were also up-regulated. Spt23p and
Mga2p regulate expression of OLE1, a gene encoding
Ole1p, an intrinsic membrane-bound -9 fatty acid desatu-
rase required for the synthesis of oleic acid in yeast cells
[32].
Pterostilbene exposure also resulted in a significant up-
regulation of genes associated with the ontology term
"response to drug" (z-score of 5.05 – Table 3; genes listed
in Table 5). Three of these genes encode transcription fac-
tors, including PDR3 involved in the regulation of the
pleiotropic drug resistance (PDR) response in yeast [33],
Determination of IC50 concentration for pterostilbene in  yeast cells Figure 1
Determination of IC50 concentration for pterostilbene in 
yeast cells. Results are shown from a microtiter assay (exper-
iment 1) and three independent assays performed in large 
scale cultures (experiment 2–4) as described in "Methods".
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Table 2: Distribution of differentially expressed genes based on fold-change of expression
Threshold Number of differentially expressed 
genes
Number of genes up-regulated Number of genes down-regulated
≥ 2 to <5-fold 1032 863 169
≥ 5 to <10-fold 113 102 11
≥ 10 to <50-fold 37 35 2
≥ 50-fold to <100-fold 5 5 0
≥ 100-fold 2 2 0BMC Medical Genomics 2008, 1:7 http://www.biomedcentral.com/1755-8794/1/7
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YAP1, encoding a basic leucine zipper transcription factor
required for oxidative stress tolerance [34], and YRR1,
encoding a Zn2-Cys6 zinc-finger transcription factor that
activates genes involved in multidrug resistance [35].
Notably, the significantly induced genes in this category
were transporters, especially the ABC transporters whose
function is known to be involved in multidrug resistance
against a broad range of antifungal agents [36]. It should
be also noted that the AZR1 gene, which encodes a plasma
membrane protein required for adaptation to acetic acid
and resistance to azole drugs such as ketoconazole and
fluconazole in yeast [37], was induced by more than 73-
fold (Table 5).
Including the transcription factors discussed above
involved in the regulation of lipid metabolism and pleio-
tropic drug resistance, in total more than 30 transcription
factors were up-regulated in response to pterostilbene (see
Additional file 3: List of pterostilbene-responding genes in
the "cell wall," "transcription factor activity," and "mito-
chondrion" categories). Of particular interest are genes
encoding transcription factors involved in mitochondrial
function (RTG1  and  RTG2), cell wall-related functions
(RLM1), and methionine metabolism (MET4  and
MET31), considering that these functional categories were
over-represented in the gene ontology analysis (Table 3).
Thus, the genes present in these functional categories
include transcription factors as well as their cognate tar-
gets, suggesting the modulation of these processes, at least
in part, via altered levels of these specific transcription fac-
tors in response to pterostilbene exposure.
In the Cellular Component-based ontology analysis,
genes required for mitochondrial and cell wall-related
Table 3: Z-score reports for selected gene ontologies represented in the transcription profile of pterostilbene-treated yeast cells
Ontology Genes Up Down Array z-up z-down
Biological process
Biosynthesis 150 104 46 871 -2.73 2.7
Response to stress 83 76 7 365 3.35 -1.92
Response to drug 13 13 02 6 5.05 -1.01
Amino acid and derivative metabolism 42 22 20 189 -1.27 5.08
Sulfur amino acid metabolism 14 2 12 30 -1.27 10.5
Aspartate family amino acid metabolism 14 1 13 41 -2.25 9.48
Methionine metabolism 11 0 11 21 -1.92 11.78
Regulation of transcription from Pol II promoter 40 36 4 169 2.4 -0.96
Reproduction 32 18 14 176 -1.77 3.01
Ion transport 27 18 9 104 0.71 2.68
Regulation of cell cycle 24 15 9 122 -0.81 2.15
Mitochondrion organization and biogenesis 20 18 27 7 2.12 -0.53
Protein folding 19 17 24 6 4.24 0.22
Molecular function
Transferase activity 99 67 32 604 -2.76 2.11
Transporter activity 87 63 24 406 0.49 2.36
Ion transporter activity 27 18 9 121 0.05 2.13
Organic acid transporter activity 12 7 5 46 0.1 2.52
ATP-binding cassette (ABC) transporter activity 10 10 02 9 3.02 -1.08
Oxidoreductase activity 59 38 21 236 0.63 4.23
ATPase activity 33 33 0 158 2.24 -2.56
Peptidase activity 25 25 0 116 2.12 -2.18
Chaperone activity 24 24 08 5 3.56 -1.86
Transcription factor activity 21 20 15 4 4.67 -0.76
Kinase regulator activity 12 5 7 36 -0.14 4.93
Cellular component
Mitochondrion 161 148 13 644 6.1 -2.23
Plasma membrane 57 38 19 215 1.13 4.31
Endoplasmic reticulum 52 37 15 364 -2.68 0.63
Cytosol 38 26 12 390 -4.8 -0.51
Cell wall 36 18 18 95 1.09 8.22
Chromosome 22 14 8 182 -2.81 0.64
Cytoskeleton 22 16 6 194 -2.68 -0.34
Z-scores were determined using GeneSifter software. Criteria for inclusion in the table were an ontology having a z-score ≥ 2 or ≤ -2 and 
containing ≥ 10 genes. Genes, number of genes differentially expressed within the assigned ontology; array, the number of genes on the microarray 
assigned to the particular gene ontology. Sub-categories within a given ontology are shown in italics. Significant z-scores and corresponding 
numbers of genes in each category are shown in bold.BMC Medical Genomics 2008, 1:7 http://www.biomedcentral.com/1755-8794/1/7
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functions were also over-represented (Table 3). The cell
wall category had a z-score of 8.22 (Table 3), and most of
the genes assigned within this category were down-regu-
lated by pterostilbene treatment (Table 3). The majority of
these genes are involved in mating responses [e.g., FIG1,
FIG2, SAG1, AGA1, MF(ALPHA)1, and MF(ALPHA)2, see
Additional file 3: op. cit.], which is also in agreement with
the over-representation of the gene ontology term "repro-
duction" in the Biological Process category (z-score of
3.01, Table 3). Additional down-regulated cell wall-
related genes included chitin synthase 2(CHS2), cell wall
mannoproteins (TIP1, CWP1) and a major exo-1,3-beta-
glucanase of the cell wall (EXG1) (see Additional file 3: op.
cit.). These genes are responsible for the biosynthesis of
three major constituents (chitin, mannoproteins and glu-
can) found in yeast cell walls [38]. The gene BAG7 (Rho
GTPase activating protein), however, was induced by
~137-fold in pterostilbene treated cells (see Additional
file 3: op. cit.). It has been reported that Bag7p plays a role
in the control of cell wall synthesis and is involved in reg-
ulating key components of the cell wall stress-response
pathway [39].
With respect to mitochondrial genes, it is interesting to
note that more than 100 genes involved in diverse mito-
chondrial functions were up-regulated by pterostilbene
Table 4: Pterostilbene-responsive genes involved in lipid metabolism
Accession Gene Ratio p-value Gene Description
a. Lipid biosynthesis/metabolism process
YBR004C GPI18 3.1 1.28 × 10-4 Functional ortholog of human PIG-V
YGL126W SCS3 2.4 1.06 × 10-3 Required for inositol prototrophy
YDR173C ARG82 2.3 2.53 × 10-4 Inositol polyphosphate multikinase (IPMK)
YGR036C CAX4 2.3 0.02 Dolichyl pyrophosphate (Dol-P-P) phosphatase
YIL124W AYR1 -2.7 6.79 × 10-4 1-acyl dihydroxyacetone phosphate reductase
YJL153C INO1 10.0 6.73 × 10-4 L-myo-inositol-1-phosphate synthase
YJL196C ELO1 -2.8 1.18 × 10-5 Elongase
YKL051W SFK1 4.0 4.36 × 10-4 Suppressor of PI Four Kinase
YMR165C PAH1 2.2 1.15 × 10-3 Mg2+-dependent phosphatidate (PA) phosphatase
YMR207C HFA1 2.0 3.22 × 10-4 Mitochondrial acetyl-coenzyme A carboxylase
YNL169C PSD1 -2.1 1.93 × 10-3 Phosphatidylserine decarboxylase
YNL231C PDR16 6.1 3.54 × 10-4 by the multiple drug resistance regulator Pdr1p
YNR043W MVD1 -2.2 3.55 × 10-4 Mevalonate pyrophosphate decarboxylase
YPR183W DPM1 -2.3 2.88 × 10-4 Dolichol phosphate mannose synthase
YKR009C FOX2 3.1 7.82 × 10-4 Multifunctional beta-oxidation protein
YLR284C ECI1 2.1 8.91 × 10-3 Peroxisomal ∆3, ∆2-enoyl-CoA isomerase
YML042W CAT2 2.4 2.21 × 10-4 Carnitine O-acetyltransferase
YMR246W FAA4 2.1 1.25 × 10-4 Long chain fatty acyl-CoA synthetase
YNR019W ARE2 4.1 1.28 × 10-4 Acyl-CoA:sterol acyltransferase
YOR100C CRC1 2.4 0.01 Carnitine transporter
YKR031C SPO14 2.1 1.36 × 10-3 Phospholipase D
YMR008C PLB1 3.9 3.37 × 10-4 Phospholipase B (lypophospholipase)
b. Sphingolipid metabolism
YBR265W TSC10 -2.4 5.46 × 10-4 3-ketosphinganine reductase
YCR034W FEN1 -3.0 3.49 × 10-4 Fatty acid elongase
YDR062W LCB2 -2.1 5.13 × 10-4 Component of serine palmitoyltransferase
YDR072C IPT1 6.5 2.64 × 10-6 Inositolphosphotransferase 1
YLR260W LCB5 3.7 8.66 × 10-4 Minor sphingoid long-chain base kinase
YOR171C LCB4 2.6 8 × 10-5 Sphingoid long-chain base kinase
YPL057C SUR1 3.5 4.67 × 10-3 Probable catalytic subunit of a mannosylinositol phosphorylceramide (MIPC) synthase
YPL087W YDC1 2.2 2.93 × 10-3 Alkaline dihydroceramidase
c. Genes involved in the regulation of lipid biosynthesis and metabolism
YAL051W OAF1 2.0 1.1 × 10-3 Oleate-activated transcription factor
YDR096W GIS1 4.0 2.12 × 10-3 Transcriptional factor
YDR213W UPC2 8.8 6.78 × 10-5 Sterol regulatory element binding protein
YOR237W HES1 3.1 4.32 × 10-3 Protein implicated in the regulation of ergosterol biosynthesis;
YIR033W MGA2 2.0 1.53 × 10-3 ER membrane protein involved in regulation of OLE1 transcription
YKL020C SPT23 2.1 7.73 × 10-4 ER membrane protein involved in regulation of OLE1 transcription
YOR049C RSB1 131.8 2.23 × 10-4 Suppressor of sphingoid long chain base (LCB) sensitivity of an LCB-lyase mutation
YOL108C INO4 2.1 5.1 × 10-3 Transcription factor required for derepression of inositol-choline-regulated genesBMC Medical Genomics 2008, 1:7 http://www.biomedcentral.com/1755-8794/1/7
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treatment (Table 3, and Additional file 3: op. cit.). These
genes play important roles in respiration, electron trans-
port, mitochondrial protein targeting, and mitochondrial
protein synthesis (see Additional file 3: op. cit.).
Of particular interest was the finding that a group of genes
involved in sulfur metabolism was significantly over-rep-
resented, generating a z-score of 10.5 for the category "sul-
fur amino acid metabolism," (the highest score obtained
in the present study). Within this category, a subset of
genes assigned to the ontology term "methionine metab-
olism" (z-score of 11.78) were down-regulated upon
exposure to pterostilbene (Table 3). Of the 21 genes
assigned to this ontology term on the array, eleven were
differentially regulated. As shown in Figure 2 and Table 6,
all responsive genes involved in sulfur-containing amino
acid biosynthesis were down-regulated, with the excep-
tion of MET4 (transcriptional activator) and MET31 (tran-
scriptional regulator), which were up-regulated (Table 6).
Validation of microarray data by quantitative real-time 
RT-PCR
For further verification of the transcript profiling results,
selected genes were analyzed by quantitative real time RT-
PCR with cDNAs prepared from the identical RNA sam-
ples used for microarray target preparations. For these
analyses, eleven genes associated with gene ontology cat-
egories discussed above were selected, including genes
involved in lipid metabolism (UPC2, OAF1, RSB1 and
INO4), sulfur metabolism (MET3), response to drug
(AZR1 and PDR3), mitochondrial functions (RTG1 and
RTG3) and cell wall-related functions (RLM1 and BAG7).
The results (Figure 3) are in agreement with the microar-
ray experiments, with ten genes showing up-regulation
and one gene (MET3) showing down-regulation in
response to pterostilbene treatment. A few discrepancies
in fold-change values between real-time RT-PCR and
microarray analyses could be attributed to technical dif-
ferences between the two methods. For example, the
genes RSB1, AZR1, and BAG7 showed a higher level of
induction in the microarray data compared to the real-
time RT-PCR data. This discrepancy could be attributed to
Table 5: Pterostilbene-responsive genes associated with "response to drug" gene ontology category
Accession Gene Ratio p-value Molecular Function
a. Multidrug resistance ABC transporters
YOR153W PDR5 6.1 6.01 × 10-5 Multidrug resistance ABC transporter
YOR328W PDR10 7.1 1.01 × 10-4 ABC transporter highly similar to Pdr5p
YGR281W YOR1 10.3 1.01 × 10-4 Multidrug resistance ABC transporter
YDR011W SNQ2 8.2 9.71 × 10-6 Multidrug resistance ABC transporter
b. Multidrug resistance MFS transporters
YNL065W AQR1 2.2 7.19 × 10-3 MFS-multidrug resistance transporter
YGR224W AZR1 73.4 2.16 × 10-4 MFS plasma membrane transporter
c. Multidrug resistance transcription factors
YBL005W PDR3 9.5 4.22 × 10-4 Transcriptional activator of the PDR network
YML007W YAP1 3.1 1.66 × 10-5 Transcription factor required for oxidative stress
YOR162C YRR1 2.5 9.44 × 10-5 Transcription factor involved in MDR
d. Other drug-responsive genes
YOR266W PNT1 2.0 0.01 Mitochondrial protein involved in export of proteins
YNL231C PDR16 6.1 3.54 × 10-4 Pdr17p homolog controlled by Pdr1p
YGR197C SNG1 4.1 3.7 × 10-4 Protein involved in nitrosoguanidine resistance
YOR018W ROD1 2.8 8.67 × 10-3 Membrane protein, resistance to o-dinitrobenzene
Summary of gene expression responses to pterostilbene in  the sulfur metabolism pathway Figure 2
Summary of gene expression responses to pterostilbene in 
the sulfur metabolism pathway. Methionine biosynthetic 
pathway and corresponding genes are based on Thorsen et 
al. [66] and the Saccharomyces Genome Database [25]. Genes 
shown in boldface in the pathway are those affected by pter-
ostilbene. The up- and down-regulated genes were indicated 
by arrows, (↑) and (↓).
L-cysteine S-adenosyl methionine
SUL1 (p)
SUL2 (p)
MET3 (p)
MET14 (p)
MET16 (p)
MET17
MET10 (p)
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MET2
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MET6 (p)
SAM1 (p)
SAM2 (p)
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the fact that the Affymetrix software assigned an "absent"
call to these genes in the untreated sample – thus the sig-
nal values assigned were artifactually low in the untreated
sample compared to the treated sample, making the fold-
change values very high [18]. Other discrepancies could
be attributed to the greater dynamic range of real-time RT-
PCR compared to microarray analysis.
Sensitivity of yeast mutants to pterostilbene
In order to further investigate the relationship between
the gene expression responses to pterostilbene and their
phenotypic consequences in yeast mutants, we analyzed a
number of yeast mutants with deletions in selected genes
from each of the categories discussed above for their sen-
sitivity to pterostilbene. The same genes selected for real-
time RT-PCR analysis were also chosen for this study, and
these included genes involved in lipid metabolism
(UPC2,  OAF1,  RSB1  and  INO4), sulfur metabolism
(MET3), response to drug (AZR1 and PDR3), mitochon-
drial functions (RTG1  and RTG3) and cell wall-related
functions (RLM1 and BAG7). As shown in Figure 4, the
loss of Pdr3p (mutant pdr3∆) resulted in increased sensi-
tivity to pterostilbene, while the loss of Upc2p, Oaf1p,
Bsr1p, Ino4, Met3p, Azr1p, Rlm1p or Bag7p resulted in
neither increased nor decreased sensitivity to pterostil-
bene under the experimental conditions used. Surpris-
ingly, the loss of Rtg1p or Rtg3p resulted in slightly
increased resistance to the compound.
Discussion
Stilbenes, such as resveratrol and pterostilbene, represent
biologically active secondary metabolites of plants known
to have diverse pharmacological properties, which
include cancer-chemopreventive activity. They are also
considered to be phytoalexins due to their potent antifun-
gal activities [14-16]. To investigate the molecular path-
ways affected by pterostilbene in eukaryotes, we
conducted DNA microarray analysis using the model
yeast S. cerevisiae, and identified large-scale transcriptome
alterations associated with pterostilbene exposure in this
organism. The responsive genes are associated with a
diversity of biological, molecular and cellular processes,
suggesting that pterostilbene exerts wide-ranging effects
on the physiological and biochemical processes of eukary-
otic cells (Tables 2 and 3).
Pterostilbene affected the expression of genes involved in
sulfur metabolism and/or sulfur assimilation, associated
Table 6: Pterostilbene-responsive genes involved in sulfur metabolism and/or assimilation
Accession Gene Ratio p-value Gene Description
a. Methionine metabolism
YJR137C ECM17 -2.5 2.48 × 10-5 Sulfite reductase beta subunit
YKR069W MET1 -3.1 3.88 × 10-4 AdoMet-dependent uroporphyrinogen III transmethylase
YJR010W MET3 -3.8 3.5 × 10-4 ATP sulfurylase
YER091C MET6 -2.4 8.83 × 10-5 Cobalamin-independent methionine synthase
YFR030W MET10 -2.1 1.5 × 10-3 Sulfite reductase alpha subunit
YGL125W MET13 -3.6 1.46 × 10-4 Methylenetetrahydrofolate reductase
YKL001C MET14 -3.1 1.12 × 10-3 Adenylylsulfate kinase
YPR167C MET16 -2.0 7.56 × 10-4 3'-phosphoadenylylsulfate reductase
YOL064C MET22 -2.5 1.68 × 10-4 Bisphosphate-3'-nucleotidase,
YLL062C MHT1 -3.4 6.69 × 10-4 S-methylmethionine-homocysteine methyltransferase
YLR180W SAM1 -2.1 6.39 × 10-5 S-adenosylmethionine synthetase
b. Sulfur and aspartate family amino acid metabolic processes (in addition to a)
YNL103W MET4 3.0 4.01 × 10-4 Leucine zipper transcriptional activator
YPL038W MET31 2.2 2.45 × 10-3 Transcriptional regulator highly homologous to Met32p
YJR130C STR2 2.3 2.97 × 10-3 Cystathionine gamma-synthase
YGL184C STR3 -3.6 4.1 × 10-3 Cystathionine beta-lyase
YJR060W CBF1 -3.0 1.11 × 10-3 Basic helix-loop-helix protein
YHR025W THR1 -2.2 2.05 × 10-4 Homoserine kinase
c. All other genes affected under the term "sulfur metabolism"
YLL060C GTT2 2.5 8.23 × 10-4 Glutathione transferase
YEL017W GTT3 -2.2 6.72 × 10-4 Protein with a possible role in glutathione metabolism
YGR286C BIO2 -3.0 9.79 × 10-4 Biotin synthase
YJL212C OPT1 -2.5 1.8 × 10-4 Peptide transporter/glutathione transporter
YLL057C JLP1 13.5 6.93 × 10-4 Fe(II)-dependent sulfonate/α-ketoglutarate dioxygenase
YLR043C TRX1 -2.1 6.95 × 10-5 Cytoplasmic thioredoxin
d. Sulfur uptake
YBR294W SUL1 -5.53 4.64 × 10-5 Sulfate uptake (transporter)
YLR092W SUL2 -2.75 1.89 × 10-4 High affinity sulfate permeaseBMC Medical Genomics 2008, 1:7 http://www.biomedcentral.com/1755-8794/1/7
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with the highest z-score in this study (Tables 3 and 6).
Within this category, six genes (ECM17, MET3, MET14,
MET16, MET10, MET6) encoding enzymes involved in
methionine biosynthesis were repressed (Figure 2, Table
6). Methionine metabolism plays an important role in
many aspects of cellular physiology. Its derivative S-ade-
nosyl methionine (SAM) serves as a methyl donor in
many biosynthetic processes [40]. Metabolism of sulfur-
containing amino acids like methionine has been linked
to cell cycle progression, and perturbations of these proc-
esses lead to diverse cellular anomalies [41,42]. The
down-regulation of genes involved in methionine biosyn-
thesis by pterostilbene may cause cellular stress by not
only decreasing methionine levels, but also by compro-
mising the supply of donor methyl groups required for
methylation reactions in various biosynthetic pathways.
Our results suggest that one of the molecular effects of
pterostilbene might involve the disruption of methionine
biosynthesis, an observation that has not been previously
reported for this compound.
The observed down-regulation of genes involved in
methionine metabolism in response to pterostilbene
treatment (Figure 2, Table 6) is perhaps surprising given
that several genes in this pathway are actually up-regu-
lated during conditions of oxidative stress and amino acid
starvation [43,44]. However, a transcriptional profiling
study conducted in yeast cells exposed to the herbicide
sulfometuron methyl (SM), which inhibits branched-
chain amino acid biosynthesis, indicated that exposure to
SM resulted in the down-regulation of several genes
involved in methionine metabolism, including MET3,
MET6, MET14, SAM1, and SAM2 [45]. One mechanism
proposed for this down-regulation was the potentially
reduced levels of ATP in SM-treated cells, given that
methionine biosynthesis and the production of SAM are
ATP-requiring processes. Interestingly, in the present work
pterostilbene treatment altered the expression of more
than 100 mitochondrial genes (Additional file 3: op. cit.),
suggesting large-scale perturbations in mitochondrial
function which would eventually lead to ATP deficiency.
A second potential mechanism emerged from queries
using MET1, MET3, MET6, MET10, MET13, MET14, and
MET16  against the Serial Pattern of Expression Levels
Locator (SPELL) database [46], which revealed that all of
the corresponding transcripts are down-regulated in
response to osmotic stress [47]. Given the significant
effects pterostilbene exposure is likely to have on lipid
metabolism (Table 4), it is possible that membrane integ-
rity could be compromised leading to an osmotic imbal-
ance in yeast cells. Consistent with this notion, genes
involved in osmotic stress response regulation such as
GRE1, GRE2, SSK1, PPZ1, and STE11  were induced in
pterostilbene-treated cells (Additional file 3: op. cit.).
Of further significance, the present results show that pter-
ostilbene up-regulated OAF1, which encodes a transcrip-
tion factor that regulates the expression of genes involved
in the beta-oxidation of fatty acids in peroxisomes in yeast
cells [28]. In addition, genes encoding enzymes required
for fatty acid β-oxidation were also up-regulated by pter-
ostilbene. It has been previously shown that pterostilbene
lowers lipid/lipoprotein levels in hypercholestrolemic
hamsters through activation of the peroxisome prolifera-
tor-activated receptor α (PPARα) [10]. PPARα is involved
in fatty acid and lipid metabolism, through the activation
of genes involved in fatty acid β-oxidation in the liver,
heart, kidney and skeletal muscles [10,48,49]. Thus, the
up-regulation of genes involved in fatty acid beta-oxida-
tion by pterostilbene in the present report is consistent
with previous observations of its effects on mammalian
cells. In addition, pterostilbene also up-regulated several
genes involved in sterol, phospholipid and sphingolipid
metabolism, including genes involved in the regulation of
lipid metabolism. Taken together, these results suggest
that lipid metabolism is likely to be an important molec-
ular pathway that is affected by pterostilbene.
Transcript levels of a number of genes involved in the plei-
otropic/multiple drug resistance response were also found
Quantitative real-time RT-PCR analysis of genes identified as  differentially expressed by microarray experiments Figure 3
Quantitative real-time RT-PCR analysis of genes identified as 
differentially expressed by microarray experiments. Assays 
were performed in triplicate as described previously [18]. 
Data were normalized to an internal control (18S rRNA) and 
the ∆∆CT method was used to obtain the relative expression 
level for each gene. Data are shown as mean ± standard devi-
ation (SD). "Ctrl" represents samples treated with solvent 
(0.25% DMSO) alone.
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to increase dramatically following pterostilbene exposure
(Table 5). These genes include ABC transporters, multid-
rug resistance transcription factors, and other drug-
responsive genes. The plasma membrane-associated efflux
pumps Pdr5p and Snq2p are under the genetic control of
the transcription factors Pdr1p and Pdr3p [50]. In yeast
cells exposed to pterostilbene, the transcripts of PDR3,
PDR5 and SNQ2 increased 9.5-, 6.1- and 8.2-fold, respec-
tively (Table 5). In addition, a yeast mutant with a dele-
tion in the PDR3 gene showed strong hypersensitivity to
pterostilbene, confirming the importance of this gene in
conferring resistance to this compound (Figure 4). Nota-
bly, the ABC transporter YOR1, involved in mediating the
export of many different organic anions including oligo-
mycin, was also up-regulated 10.3-fold in pterostilbene-
treated cells. Moreover, the expression of a plasma mem-
brane transporter, encoded by AZR1, which is involved in
the resistance to azole drugs, dramatically increased by
73.4-fold following exposure. Taken together, the strong
up-regulation of this set of transporters suggests that drug
efflux is one of the major mechanisms involved in the cel-
lular detoxification of pterostilbene in yeast cells.
As mentioned above, an additional outcome from the
present work is the observation of the up-regulation of a
large number of genes involved in diverse mitochondrial
functions, including mitochondrial respiration, mito-
chondrial protein synthesis and mitochondrial protein
targeting (associated with a z-score of 6.1 – Tables 3, and
Additional file 3: op. cit.). Furthermore, RTG1 and RTG3,
genes encoding transcription factors that play an impor-
tant role in regulating the communication between the
mitochondria and the nucleus in yeast cells, were up-reg-
ulated by pterostilbene. Mitochondria are vital for energy
production, and their disruption in humans has been
implicated in aging, diabetes, heart disease, and various
neurodegenerative disorders [51]. Recently, one of the
mechanisms by which pterostilbene induces apoptosis in
human gastric carcinoma cells was found to involve the
activation of the caspase cascade via the mitochondrial
pathway [52]. Thus, the induction of mitochondrial genes
Growth of selected yeast mutant strains in the presence of pterostilbene Figure 4
Growth of selected yeast mutant strains in the presence of pterostilbene. A parent strain BY4742 and 11 mutants (upc2∆, 
oaf1∆, rsb1∆, ino4∆, met3∆, azr1∆, pdr3∆, rtg1∆, rtg3∆, rlm1∆, and bag7∆) were analyzed. Serial dilutions of overnight cultures 
were spotted onto solid YPD (pH 7.0, MOPS buffered) agar plates containing either 1% DMSO or 110 µM pterostilbene, and 
the plates were photographed after incubation for 2 days at 30°C.
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by pterostilbene in the present study is apparently consist-
ent with its effects on this organelle in human cancer cell
lines.
Of the eleven mutants tested carrying deletions in selected
genes from pterostilbene-responsive pathways, only the
pdr3∆  mutant showed hypersensitivity to pterostilbene
(Figure 4). Lack of correlation between transcriptional
profiling and deletion mutant analyses has been reported
in the literature by investigators using both selected indi-
vidual mutants as well as whole-genome mutant popula-
tions [53-57]. Such discrepancies could be attributable to
factors such as post-transcriptional regulation of target
genes [56], functional redundancy [53], as well as the spe-
cific nature of the inhibitor tested (e.g., genes required for
survival in the presence of the inhibitor could be distinct
from those which are transcriptionally responsive; [55]).
Nevertheless, the hypersensitivity to pterostilbene exhib-
ited by the pdr3∆ mutant in the present study, coupled
with elevated levels of PDR3 as well as other multidrug
resistance-related transcripts (Figure 4, Table 5), confirms
the importance of efflux-mediated detoxification path-
ways in the cellular response to this compound. Further
mechanistic insights could potentially be gained by
extending these analyses to whole-genome mutant collec-
tions of S. cerevisiae generated by The Saccharomyces
Genome Deletion Project [57], which have been success-
fully used by others for the identification of molecular tar-
gets of various clinically relevant drugs, as well as for the
investigation of interactions between the cellular path-
ways affected [58-61]. Such studies, coupled with tran-
scriptional profiling experiments, could provide further
corroborative evidence indicating the relevance of specific
genes to the mechanism of action of pterostilbene.
The present study provides an overview of the major tran-
scriptional responses to pterostilbene using the model
eukaryote S. cerevisiae. While transcriptional profiling was
employed as the principal tool to investigate the molecu-
lar effects of pterostilbene, an examination of the
response of the yeast proteome would further refine our
understanding of pterostilbene-induced gene expression
changes, given that transcript and protein levels do not
correlate in all cases [62-65]. Additionally, the transcrip-
tional profiling results presented in the current work rely
on a single drug concentration (IC50) and time point (one
doubling), thus it is likely that many of the transcriptional
responses observed represent indirect consequences of
drug exposure. An expansion of the current data set to
include multiple time points and drug concentrations
could therefore prove invaluable in distinguishing
between the primary and secondary effects of pterostil-
bene, such as mechanism-related vs. adaptation-related
cellular responses. Nevertheless, the present work yields
important clues and provides a foundation for further
studies directed towards elucidating the precise mecha-
nism of action of pterostilbene.
Conclusion
We have identified the molecular pathways affected by
pterostilbene, and our results show that pterostilbene
affects the expression of a diverse group of genes in yeast
cells. Using Gene Ontology-based analysis, the most sig-
nificant effects were observed in genes involved in
"methionine metabolism," "response to drug," "transcrip-
tion factor activity," and "mitochondrion" functions.
Additional analyses indicated that many genes involved
in lipid metabolism were also affected. The observed
response of lipid metabolism genes is in agreement with
the known hypolipidemic properties of pterostilbene
mediated through the activation of PPARα. The induction
of a large number of mitochondrial genes by pterostilbene
is consistent with its previously-demonstrated role in
apoptosis in human cancer cells. Our data also show that
pterostilbene has a significant effect on methionine
metabolism, perhaps resulting in the depletion of methio-
nine by the inhibition of methionine biosynthesis. The
effect of pterostilbene on methionine metabolism has not
been previously observed and merits further investiga-
tion.
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